Europe Point-of-Care Testing (POCT) Market Report and Forecast 2026-2032

Europe Point-of-Care Testing (POCT) Market Insights & Analysis

The Europe Point-of-Care Testing (POCT) Market reached a value of nearly USD 8.52 billion in 2025. The market is assessed to grow at a CAGR of around 9.04%, during the forecast period of 2026-2032 to attain a value of around USD 14.32 billion in 2032. The industry is fueled by rising demand for quick diagnostics, the aging population, and the increasing burden of chronic & infectious diseases. Also, the market size is projected to continue to grow in both clinical & at-home settings owing to progressions in diagnostic technologies & healthcare decentralization.

Moreover, POCT devices are compact & portable diagnostic tools that permit immediate test results at or near the patient site, substantially decreasing the turnaround time in comparison to conventional laboratory testing. Further, these devices are broadly deployed for infectious disease testing, cardiometabolic assessments, glucose monitoring, and coagulation monitoring, etc., hence creating prospects for the Europe Point-of-Care Testing (POCT) Market.

Additionally, several aspects are hastening the acceptance of point-of-care diagnostics across the landscape of the European countries. The increasing investments in decentralized healthcare models, together with growing awareness about early disease detection, are contributing to enhancing the Europe Point-of-Care Testing (POCT) Market share. Also, the incorporation of AI-based diagnostics & smartphone-compatible devices has transformed patient engagement, predominantly in remote & rural areas.

Besides, promising regulatory reforms & investment by the European Union for healthcare modernization have enhanced access to POCT across underserved regions. Also, as healthcare swings from reactive to preventive care, the requirement for rapid, dependable, and user-friendly diagnostic solutions would continue to expand.

Consequently, the Europe Point-of-Care Testing (POCT) Market presents favorable growth opportunities, driven by technological developments, rising healthcare expenditure, the popularity of lifestyle-related diseases, and an aging demographic. Also, the industry is foreseen to observe swift innovation in molecular diagnostics & wearable biosensors, presenting real-time health data to both patients & providers in the future years.

Europe Point-of-Care Testing (POCT) Market Upgrades & Recent Developments

2025:

• Abbott Laboratories introduced its next-generation i-STAT Alinity platform in Europe, offering advanced blood analysis diagnostics with quicker result delivery & connectivity for improved clinical decisions.
• F. Hoffmann-La Roche Ltd. launched its Cobas pulse system for hospital settings, incorporating smartphone-style interface technology with lab-grade diagnostic precision, further linking the gap between POCT & central labs.
• BioMerieux SA extended its BioFire FilmArray platform portfolio in Europe to include additional respiratory & gastrointestinal panels to reinforce infectious disease management.

Europe Point-of-Care Testing (POCT) Market Dynamics

• Driver: Rising Demand for Rapid Diagnostics to Drive the Industry

The imperative requirement for faster diagnosis & treatment, specifically in emergency departments & remote care settings, is a key driver. POCT devices allow clinicians to make real-time decisions, decreasing hospital stay durations & enhancing patient outcomes. Also, the increasing popularity of diabetes, cardiovascular conditions, and infectious diseases further solidifies the market demand.

• Challenge: Regulatory Compliance & Accuracy Issues to Hamper the Market Growth

Despite their suitability, POCT devices face issues regarding test reliability, operator errors, and varying results in varied platforms. Also, safeguarding regulatory compliance across nations & maintaining standardization creates a substantial challenge for manufacturers in the regional market.

• Opportunity: Incorporation of AI & Connectivity to Open New Avenues

There is an increasing opportunity to integrate AI algorithms & IoT capabilities into POCT devices to offer remote monitoring, smart data insights, and predictive diagnostics. This would benefit both patients & healthcare professionals by streamlining diagnostics & personalizing treatment.

• Trend: Miniaturization & Home-based POCT Devices to be Trending

The Europe Point-of-Care Testing (POCT) Market is witnessing a trend toward compact, user-friendly POCT devices that allow testing at home. This is compelled by customers' demand for convenience, privacy, and real-time health tracking, specifically among chronic disease patients & aging populations.

Europe Point-of-Care Testing (POCT) Market Segment-Wise Analysis

By Technology:

• PCR-based
• Genetic Sequencing-based
• Hybridization-based
• Microarray-based

PCR-based Technology leads the Europe POCT Market, due to its superior sensitivity & specificity in identifying pathogens & genetic markers. PCR-based POCT is becoming more extensively deployed in prenatal testing, cancer, and STI diagnosis, in addition to infectious disorders. Its flexibility & capacity to recognize various diseases at once make it the go-to option, primarily in emergency rooms of hospitals & community health facilities where rapid choices are vital. Also, throughout the forthcoming period, PCR's dominance is predicted to be sustained by ongoing developments in reagent stability & device portability.

By End User:

• Decentralized Labs
• Hospitals
• Homecare
• Assisted Living Healthcare Facilities
• Other

Hospitals seize the largest share in the Europe Point-of-Care Testing Market, as they are the chief adopters of advanced diagnostic solutions for urgent care & chronic disease management. Owing to the increasing demand for bedside diagnostics, POCT is becoming essential for enhancing patient outcomes & response times, specifically in emergency & critical care units. Also, glucose monitoring, coagulation testing, blood gas analysis, heart indicators, and other procedures are performed in hospitals deploying POCT. Moreover, POCT is being rapidly incorporated into the workflow of European hospitals, owing to the surge in patient volume & the requirement for early diagnosis.

Country Projection of the Europe Point-of-Care Testing (POCT) Industry

The Europe Point-of-Care Testing (POCT) Market is geographically diversified, covering:

• The UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Russia
• The Netherlands

Germany dominates the Europe POCT Market by grabbing the potential market share. This is generally due to its robust international diagnostic market, high healthcare investment, and well-developed healthcare infrastructure. Also, with the assistance of government programs motivating early disease detection & healthcare digitization, the country is home to numerous innovation hotspots. Additionally, Immunoassay & PCR-based POCT devices have been broadly embraced by German labs & hospitals, particularly for infectious & cardiometabolic disorders. 

Furthermore, there is a larger demand for home-based POCT kits due to the aging population & an upsurge in chronic illness occurrences. Further, the creation of AI-integrated diagnostic platforms is also being driven by partnerships between medical facilities & academic institutions, assuring Germany's leadership in the Europe Point-Of-Care Diagnostics Industry.

What Does Our Europe Point-of-Care Testing (POCT) Market Research Study Entail?

• The Europe Point-of-Care Testing (POCT) Market Research Report highlights the forecast growth rate (CAGR) by anticipating the market size and share.
• The market analysis puts light upon the primary industry trends, driving aspects, potential opportunities, growth challenges, and other major factors.
• The Europe Point-of-Care Testing (POCT) Market Research Report entails details about the most critical shifts in market share in the prominent regions.
• Considering the statistics & the developments by the primary market competitors, our report also strives to demonstrate the most sought-after strategies of the key players.